News Archives - Page 2 of 35

Skip to content

Pathways & Perspectives with Ann LaCasce, MD, MMSc
Elise Chong, MD, discusses real-world CIBMTR analysis of liso-cel in R/R MCL
Shakira Grant, MBBS, MSCR, presents on how AI impacts pathology and treatment decisions
SOHO France holds its 5th meeting in the region
Blood Cancer United president reflects on 75 years of progress in blood cancer treatment

Insider Reader Survey

Join SOHO

Insider Podcast
Hem/Onc Library
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
Meeting News
Multimedia
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Experts offer advice on treating patients with belantamab mafodotin-based combinations in myeloma

by SOHO Insider Editors
October 7, 2026
0 Comments

Leukemia Chronic Lymphocytic Leukemia Lymphoma Indolent B-Cell Lymphomas News

China NMPA approves pirtobrutinib in CLL/SLL across all lines of therapy

by SOHO Insider Editors
September 30, 2026
0 Comments

Meetings / Conferences SOHO 2026 Acute Myeloid Leukemia MDS News News Society Updates Young Investigator Program

Meet some of the SOHO 2026 Young Investigators

by SOHO Insider Editors
September 28, 2026
0 Comments

Myeloproliferative Neoplasms News

FDA approves 1st new treatment for essential thrombocythemia in nearly three decades

by SOHO Insider Editors
September 24, 2026
0 Comments

Meetings / Conferences SOHO 2026 Acute Lymphoblastic Leukemia News News

Dose-dense mini-CVD plus inotuzumab ozogamicin, blinatumomab demonstrates deep, durable responses in relapsed or refractory B-ALL

by Patrick Daly
September 23, 2026
0 Comments

Silver,Spring,,Md,,Usa,-,June,25,,2022:,The,Fda

Myeloproliferative Neoplasms Primary Myelofibrosis News

FDA receives sNDA for selinexor, ruxolitinib in myelofibrosis

by SOHO Insider Editors
September 22, 2026
0 Comments

Myelodysplastic Syndromes News

LYT-200 receives FDA Fast Track Designation for relapsed or refractory high-risk MDS

by SOHO Insider Editors
September 22, 2026
0 Comments

News Society Updates

4th SOHO Israel Meeting registration open, meeting to be held November 19–20, 2026

by SOHO Insider Editors
September 22, 2026
0 Comments

News

Fibrotic low-risk MDS associated with elevated IL-1β and reduced IL-5

by Leah Sherwood
September 13, 2026
0 Comments

Soho Print News

SOHO Insider Daily, Newspaper Volume 4

by Leah Sherwood
September 12, 2026
0 Comments

1
2
3
4
...
35

Top Categories

Cellular Therapy

81

Leukemia

145

Lymphoma

145

Multiple Myeloma

126

Myelodysplastic Syndromes

52

Myeloproliferative Neoplasms

40

POPULAR NEWS

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About Us

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Contact Info

China NMPA approves pirtobrutinib in CLL/SLL across all lines of therapy

Meet some of the SOHO 2026 Young Investigators

FDA approves 1st new treatment for essential thrombocythemia in nearly three decades

Dose-dense mini-CVD plus inotuzumab ozogamicin, blinatumomab demonstrates deep, durable responses in relapsed or refractory B-ALL

FDA receives sNDA for selinexor, ruxolitinib in myelofibrosis

LYT-200 receives FDA Fast Track Designation for relapsed or refractory high-risk MDS

4th SOHO Israel Meeting registration open, meeting to be held November 19–20, 2026

Fibrotic low-risk MDS associated with elevated IL-1β and reduced IL-5

SOHO Insider Daily, Newspaper Volume 4

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Society Updates

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Recent Posts

Pathways & Perspectives with Ann LaCasce, MD, MMSc

Elise Chong, MD, discusses real-world CIBMTR analysis of liso-cel in R/R MCL

Shakira Grant, MBBS, MSCR, presents on how AI impacts pathology and treatment decisions

About Us

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Contact Info

Follow Us

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Society Updates

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms